![]() |
When CDK12/13 stalls, healthy prostate cells take a malignant turn
CDK12 is established as a tumor suppressor in prostate cancer, with its loss driving aggressive disease and creating vulnerabilities for targeted therapies.
More... |
| All times are GMT -7. The time now is 03:19 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021